For instance, HO-1 overexpression is involved in resistance to chemo- and radio-therapy in central nervous system malignancies [113] and in resistance to cisplatin in hepatoma cells and ovarian cancer cells [143,144]. Here, HMOX1 is linked to ovarian carcinoma.